Zobrazeno 1 - 10
of 20
pro vyhledávání: '"Isabel, Garau"'
Autor:
Fara Brasó-Maristany, Gaia Griguolo, Tomás Pascual, Laia Paré, Paolo Nuciforo, Antonio Llombart-Cussac, Begoña Bermejo, Mafalda Oliveira, Serafín Morales, Noelia Martínez, Maria Vidal, Barbara Adamo, Olga Martínez, Sonia Pernas, Rafael López, Montserrat Muñoz, Núria Chic, Patricia Galván, Isabel Garau, Luis Manso, Jesús Alarcón, Eduardo Martínez, Sara Gregorio, Roger R. Gomis, Patricia Villagrasa, Javier Cortés, Eva Ciruelos, Aleix Prat
Publikováno v:
Nature Communications, Vol 11, Iss 1, Pp 1-11 (2020)
HER2-enriched breast cancers within the HER2-positive subtype are addicted to the HER2 pathway. Here, the authors analyse gene expression before, during, and after treatment with anti-HER2-based therapies in the phase II PAMELA clinical trial, findin
Externí odkaz:
https://doaj.org/article/76ae9021acef4670a550a57d2950a303
Autor:
Aleix Prat, Xavier Gonzalez, Paolo Nuciforo, Jordi Canes, Patricia Galván, Débora Martínez, Blanca González-Farré, Estela Vega, María J. Echarri, Serafin Morales, Begoña Bermejo, Alvaro Montaño, Noelia Martínez, Mireia Melé, Isabel Garau, Antonia Perelló, Silvia Vazquez, Javier Cortés, Eduardo Martínez, Barbara Adamo, Luis Manso, Santiago Escrivá-de-Romaní, Laia Paré, Sonia Pernas, Mafalda Oliveira, Tomás Pascual, Patricia Villagrasa, Eva Ciruelos
Purpose:To assess palbociclib in combination with trastuzumab with or without endocrine therapy in patients with HER2-positive advanced breast cancer.Patients and Methods:PATRICIA is a prospective, open-label, multicenter phase II trial. Patients had
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cbe641c6208c4c76eba99d4adff8ffc6
https://doi.org/10.1158/1078-0432.c.6529797.v1
https://doi.org/10.1158/1078-0432.c.6529797.v1
Autor:
Aleix Prat, Xavier Gonzalez, Paolo Nuciforo, Jordi Canes, Patricia Galván, Débora Martínez, Blanca González-Farré, Estela Vega, María J. Echarri, Serafin Morales, Begoña Bermejo, Alvaro Montaño, Noelia Martínez, Mireia Melé, Isabel Garau, Antonia Perelló, Silvia Vazquez, Javier Cortés, Eduardo Martínez, Barbara Adamo, Luis Manso, Santiago Escrivá-de-Romaní, Laia Paré, Sonia Pernas, Mafalda Oliveira, Tomás Pascual, Patricia Villagrasa, Eva Ciruelos
Supplementary Data
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8a283baaa55ffa3c6a6f625352454b0a
https://doi.org/10.1158/1078-0432.22477938
https://doi.org/10.1158/1078-0432.22477938
Autor:
Jose Ignacio Chacon, Miguel Gil, Elisa Garcia-Garre, Isabel Garau Llinas, Guillermo Lopez-Vivanco, Luis Manso, Manuel Ramos Vazquez, Andrés Redondo, César A. Rodríguez
Publikováno v:
Repositorio Institucional de la Consejería de Sanidad de la Comunidad de Madrid
Consejería de Sanidad de la Comunidad de Madrid
Consejería de Sanidad de la Comunidad de Madrid
Background: Randomized controlled trials of the first-line combination of bevacizumab and chemotherapy in patients with metastatic breast cancer (MBC) have shown improvements in tumor response and progression-free survival (PFS). Objective: The aim o
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::63ac9cea45a60f68be5e33b3b5ae618d
https://doi.org/10.2147/ott.s170303
https://doi.org/10.2147/ott.s170303
Autor:
Isabel Garau, Marcela Sediva, Cecilia de Almeida Agudo, Beata Freier, Sandro Barni, Gilles Berdeaux, Claudio Zamagni, Jean-Loup Mouysset
Publikováno v:
Current medical research and opinion. 32(11)
To assess the burden of disease associated with advanced breast cancer (ABC) treated with oral (VinO) or intravenous vinorelbine (VinIV) from the perspective of patients and caregivers in five European countries.This was an observational, prospective
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::072e17c827b409ccdb9260e70a90a7ab
https://pubmed.ncbi.nlm.nih.gov/27388853
https://pubmed.ncbi.nlm.nih.gov/27388853
Autor:
Wolfgang Ahrens, Laila Østergren, Mauri Johansson, Isabel Garau, Minna Loponen, Gemma Janer, Paolo Boffetta, Timo Partanen, Rainer Frentzel-Beyme, Jürgen Tempel, Manolis Kogevinas, Leif Svanström, Päivi Peltomäki, Maria Dolores Solér, Freddy Brenes, Maria Sala, Carmen Font, Tarja Kallas-Tarpila, Kaisa Neuvonen, Catharina Wesseling
Publikováno v:
Preventive Medicine. 35:232-240
Background. A simple empirically based method for assessment of the feasibility of workplace health promotion programs is described, focusing on cancer hazards (lifestyles, workplace hazards, deficient early detection). The basic components of feasib
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8783618a6b2d23be04e87c2a7e7e18ac
https://doi.org/10.1006/pmed.2002.1065
https://doi.org/10.1006/pmed.2002.1065
Autor:
Redondo, Andrés, Vázquez, Manuel Ramos, Manso, Luis, Gil, Miguel J Gil, Llinas, Isabel Garau, García-Garre, Elisa, Rodríguez, César A, Chacón, José Ignacio, López-Vivanco, Guillermo
Publikováno v:
OncoTargets & Therapy; Sep2018, Vol. 11, p5845-5852, 8p
Autor:
Jordi Oliver, Pilar Roca, Jorge Sastre-Serra, Magdalena García-Bonafé, Isabel Garau, Daniel Gabriel Pons, Adamo Valle, Mercedes Nadal-Serrano
Publikováno v:
Free radical biologymedicine. 61
Estrogen receptor status is a diagnostic parameter in breast cancer treatment. Estrogen receptor presence is related to a better prognosis because the principal treatments attacking breast cancer tumors have their action site directed at the estrogen
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c3f644f67f169914443184c411a89e6a
https://pubmed.ncbi.nlm.nih.gov/23499841
https://pubmed.ncbi.nlm.nih.gov/23499841
Autor:
Claudia Allemani, Pascale Grosclaude, Isabel Garau, Giovanna Tagliabue, Adele Traina, Hans H. Storm, Ana Torrella-Ramos, Arlette Danzon, Milena Sant, G. Hedelin, Laufey Tryggvadottir, Karin Peignaux, Kaija Holli, Massimo Federico, Magdalena Bielska-Lasota, Maja Primic-Zakelj, IsabeI Izarzugaza, Marina Vercelli, Eva Ardanaz, Tiiu Aareleid, Marc Colonna, I Plesko, Carmen Martinez-Garcia, Jadwiga Rachtan, Rosario Tumino, Emanuele Crocetti, Adri C. Voogd
Publikováno v:
European Journal of Cancer
European Journal of Cancer, Elsevier, 2010, 46 (9), pp.1528-1536. 〈10.1016/j.ejca.2010.02.016〉
European Journal of Cancer, Elsevier, 2010, 46 (9), pp.1528-1536. ⟨10.1016/j.ejca.2010.02.016⟩
European Journal of Cancer, 46(9), 1528-1536. ELSEVIER SCI LTD
European Journal of Cancer, Elsevier, 2010, 46 (9), pp.1528-1536. 〈10.1016/j.ejca.2010.02.016〉
European Journal of Cancer, Elsevier, 2010, 46 (9), pp.1528-1536. ⟨10.1016/j.ejca.2010.02.016⟩
European Journal of Cancer, 46(9), 1528-1536. ELSEVIER SCI LTD
International audience; On a population-based sample of 13,500 European breast cancer patients mostly diagnosed in 1996-1998 and archived by 26 cancer registries, we used logistic regression to estimate odds of conservative surgery plus radiotherapy
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a9169a99281f84ec2220e0fe5bf9fcf7
https://hal.archives-ouvertes.fr/hal-00493663
https://hal.archives-ouvertes.fr/hal-00493663
Autor:
Enrique Benito Oliver, Isabel Garau Llinás, Antonio Avellá Mestre, Ana Proenza Arenas, Onofre Pons Sureda, Gustavo Catalán Fernandez, Pilar Roca Salom
Publikováno v:
Gaceta Sanitaria. 6(28):25-29
ResumenSe estudia la prevalencia del consumo de tabaco en Mallorca, analizando las variables relacionadas con el mismo, a través de una encuesta domiciliaria de una muestra de 300 sujetos seleccionados al azar del censo electoral de 1986, entre los
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::841c221c2287b40639bc6e7576a8030b